India Q1 pharma exports up 7%, U.S. is largest export destination
Pharmexcil data shows India’s pharmaceutical exports rose year-on-year in the first quarter ending June to about $8.1 billion, with the United States as the top destination.
GS3GS2The HinduGS3Pharmaceutical exportsTrade performance and market destinationsPharmexcil
What happened: India’s pharmaceutical exports rose in the first quarter ending June
Pharmexcil reported year-on-year growth in India’s pharmaceutical exports for the first quarter ending June. Total exports reached about $8.1 billion, and the United States remained the largest country destination.
Product-wise breakup in Q1 (ending June)
Pharmexcil’s category-wise figures for the first quarter ending June are:
Drug formulations and biologicals: about $5.98 billion, close to three-quarters of total exports.Bulk drugs and intermediates: about $1.36 billion.Vaccine exports: around $0.39 billion.Surgical products: about $0.21 billion.
Destination markets: North America and Europe dominate; the United States leads
